Recombinant epidermal growth factor drop (Pavay Gene Pharmaceutical)
重组人表皮生长因子滴眼液（桂林华诺威基因药业）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant epidermal growth factor drop (Pavay Gene Pharmaceutical)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2002/04/12
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuilin Huanuowei Gene Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesGuilin Huanuowei Gene Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A